预测阿尔茨海默病的基因表达特征,使用死后脑组织.
Ashley H Duche1, Oliver Tan1, Andrius Baskys2
1Pharmacy Practice Department, School of Pharmacy, Chapman University, Irvine, CA, United States.
Frontiers in aging neuroscience
|October 20, 2025
概括
这项研究确定了基因表达特征,揭示了阿尔茨海默病 (AD) 区域脆弱性的分子机制. 这些发现突出了细胞外矩阵过程和荷尔蒙通路,表明了新的治疗点,如AD的FGFR抑制剂.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是粉样β (Aβ) 斑块和聚合物.
- 在早期阿尔茨海默氏症病原体中区域脆弱性的机制尚未完全理解.
- 这项研究旨在探索潜在的AD病理的区域敏感性的分子机制.
研究的目的:
- 开发用于预测阿尔茨海默病区域脆弱性的基因表达特征.
- 识别导致AD病理差异的分子途径和遗传因素.
- 发现治疗干预的潜在药物重用候选人.
主要方法:
- 使用了来自ROSMAP,梅奥诊所和MSBB队伍的死后脑组织.
- 通过适应性特征选择和整合 (ASSIGN) 来导出和验证基因表达特征.
- 通过CMAP分析了途径失调,遗传/社会人口因素,并通过CMAP确定了候选药物.
主要成果:
- 预测特征在6个大脑区域区分了AD活动和严重程度.
- 确定了细胞外基质 (ECM) 过程的上调和荷尔蒙信号通路的下调.
- 发现了S100A4的持续上调和CRH的下调;突出了APOE基因型和性别的影响;确定了FGFR和原体抑制剂作为潜在的治疗方法.
结论:
- 分子签名为理解AD进展驱动器提供了一个框架.
- ECM和荷尔蒙通路是AD中区域敏感性的关键因素.
- 已识别的药物重用候选药物需要进一步研究AD治疗.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...